Neurocrine Biosciences
NBIX
#1486
Rank
NZ$24.54 B
Marketcap
NZ$246.16
Share price
0.10%
Change (1 day)
2.09%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company